Stem Cell Therapy International, Inc. (OTC: SCII), a leading company in the field of research and development of stem cell transplantation (SCT) therapy and regenerative medicine, announced today the successful results of a case of stem cell transplantation recently concluded in Kiev, Ukraine, on Ian McBride, 49, a stroke victim from Belfast, Ireland.

Mr. McBride, a former porter in the City Hospital in Belfast, Ireland, whose left arm and left leg were paralyzed as a result of a stroke 18 months ago, had undergone traditional treatment for stroke victims in various clinics and hospitals in Ireland. His doctors held out no hope that Mr. McBride could recover mobility in these limbs.

As a result of the transplantation of stem cells into his body, Mr. McBride can now lift and bend his left leg and can move his left arm, as well as grip the side of the bed or someone’s hand with his left hand and was able to sit up on his own. Something he was unable to do since he suffered the stroke.

SCTI has posted a Video Clip on its web site displaying Mr. McBride demonstrating his left side mobility and hear him testify as to the results of the therapy.

Calvin Cao, CEO of Stem Cell Therapy International said, “We have asked Dr. Weiwen Deng, MD., Ph.D., an expert in stem cell therapy from Tulane University and a member of the SCTI Medical Advisory Board, to prepare a scientific abstract on the case and submit it to an appropriate scientific journal for publication. This case, we believe, will encourage stem cell researchers around the world to strengthen their efforts to gain acceptance for the widespread use of stem cell therapy.”

Mr. Cao reported that at the suggestion of the SCTI Medical Advisory Board, Mr. McBride is scheduled to return to the clinic in Kiev in six months for additional stem cell transplantation therapy to help speed up the healing process of his entire body.

Stem cell transplantation therapy is a field of medicine which uses techniques and technologies that rely on replacing diseased, damaged or dysfunctional cells with healthy, functioning ones. This therapy is similar to the process of organ transplantation, only the treatment consists of the transplantation of stem cells into the body rather than entire organs, thus eliminating any chance of rejection or the need for expensive and potentially dangerous immunosuppression drug therapy.

These new techniques are being applied to finding a cure for a wide range of human disorders, including neurological diseases such as Alzheimer’s, Parkinson’s Disease, ALS, (also commonly known as Lou Gehrig’s disease), leukemia, muscular dystrophy, multiple sclerosis, arthritis, spinal cord injuries, brain injury, stroke, heart disease, liver and retinal disease, diabetes as well as certain types of cancer and can be used to alleviate the side effects of chemotherapy.

Contact Information
Stem Cell Therapy
International
Calvin C. Cao
Chairman and CEO
Stem Cell Therapy
International
T: 813-600-4088
E: calvin@scticorp.com

Investor Relations
Arun Chakraborty
Investor Relations
Stern & Co.
T: 212-888-0044
E: achakrab@sternco.com

Media Relations
Stan Froelich
VP, Media Relations
Stern & Co.
T: 212-888-0044
E: sfroelich@sternco.com

Sourcee: Press Release of Stem Cell Therapy International, Inc.